Skip to main content

Home/ Health Now/ Group items tagged Alzheimer's

Rss Feed Group items tagged

Matti Narkia

Soybean Product Fights Abnormal Protein Involved In Alzheimer's Disease - 0 views

  •  
    ScienceDaily (Feb. 20, 2009) - A vegan food renowned in Asia for its ability to protect against heart attacks also shows a powerful ability in lab experiments to prevent formation of the clumps of tangled protein involved in Alzheimer's disease, scientists in Taiwan are reporting. \n\nRita P. Y. Chen and colleagues point out that people in Asia have been eating natto - a fermented food made from boiled soybeans -for more than 1,000 years. Natto contains an enzyme, nattokinase, that has effects similar to clot-busting drugs used in heart disease.Nattokinase is sold a dietary supplement to impro 
Matti Narkia

Weekly curry 'may fight dementia' - BBC NEWS | Health - 0 views

  •  
    Eating a curry once or twice a week could help prevent the onset of Alzheimer's disease and dementia, a US researcher suggests. The key ingredient is curcumin, a component of the spice turmeric.
Matti Narkia

Prevalence of Vitamin D Insufficiency in Patients With Parkinson Disease and Alzheimer ... - 0 views

  •  
    Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease.\nEvatt ML, Delong MR, Khazai N, Rosen A, Triche S, Tangpricha V.\nArch Neurol. 2008 Oct;65(10):1348-52.\nPMID: 18852350
Matti Narkia

Sham vs. Wham: The Health Insider: Fermented Asian Food Shown to Have Possible Protecti... - 0 views

  •  
    People in Asia have been eating fermented foods for more than 1,000 years. One vegan fermented food, renowned in Asia for its ability to protect against heart attacks, was recently shown to have a powerful ability in lab experiments to prevent formation of the clumps of tangled protein involved in Alzheimer's disease. if this works as well in the human brain as scientists expect, it will be a great addition to the tables of anyone who is concerned about this terrible disease
Matti Narkia

Vitamin D Newsletter March 2009 | All Things Vitamin D - 0 views

  •  
    This is a very long newsletter. I will answer questions about oil versus water-soluble Vitamin D, depression, mental clarity, malignant melanoma, Crohn's disease, an imagist poet, multiple sclerosis, sun-exposure, high-intensity red light and collagen repair in the skin, non-alcoholic fatty liver disease, influenza, the 1918 influenza pandemic, statins, the new Food and Nutrition Board, thyroid disease, chronic fatigue syndrome, athletes, the upcoming 14th Vitamin D Workshop, prostate cancer, the wrong blood test, pregnancy, autism, Alzheimer's disease, soap and sebum, asthma, sleep, the co-factors vitamin D needs to work (all contained in spinach), and-my favorite-UVC light and Vitamin D
Sue Cifelli

Reversal Of Alzheimer's Symptoms Within Minutes In Human Study - 0 views

  • Reversal Of Alzheimer's Symptoms Within Minutes In Human Study ScienceDaily (Jan. 9, 2008) — An extraordinary new scientific study, which for the first time documents marked improvement in Alzheimer’s disease within minutes of administration of a therapeutic molecule, has just been published in the Journal of Neuroinflammation.
    • tgkuo1 Kuo
       
      新發現
  •  
    new discovery of alzheimer study.
Matti Narkia

Green tea 'slows prostate cancer' - BBC NEWS | Health - 0 views

  •  
    A chemical found in green tea appears to slow the progression of prostate cancer, a study has suggested. Green tea has been linked to a positive effect on a wide range of conditions, including heart disease, cancer and Alzheimer's disease.
Matti Narkia

Amyloid-degrading ability of nattokinase from Bacillus subtilis natto. - J Agric Food C... - 0 views

  •  
    Amyloid-degrading ability of nattokinase from Bacillus subtilis natto. Hsu RL, Lee KT, Wang JH, Lee LY, Chen RP. J Agric Food Chem. 2009 Jan 28;57(2):503-8. PMID: 19117402 DOI: 10.1021/jf803072r\n
Matti Narkia

Phospholipase A(2) activation as a therapeutic approach for cognitive enhancement in ea... - 0 views

  •  
    Phospholipase A(2) activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease. Schaeffer EL, Forlenza OV, Gattaz WF. Psychopharmacology (Berl). 2009 Jan;202(1-3):37-51. Epub 2008 Oct 14. PMID: 18853146 DOI: 10.1007/s00213-008-1351-0
1 - 20 of 20
Showing 20 items per page